机构:[1]Zhongshan Chenxinghai Hospital, Guangdong Medical University, Zhongshan, China[2]Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China[3]Department of Neurosurgery, Affiliated Hospital of Youjiang Medical College for Nationalities, Baise, Guangxi, China
Regional fund of the National Natural Science Foundation of China (No. 81780450).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类|4 区医学
小类|4 区肿瘤学4 区病理学
最新[2025]版:
大类|4 区医学
小类|4 区肿瘤学4 区病理学
第一作者:
第一作者机构:[1]Zhongshan Chenxinghai Hospital, Guangdong Medical University, Zhongshan, China
通讯作者:
通讯机构:[2]Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China[*1]Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510310, Guangdong, China
推荐引用方式(GB/T 7714):
Bao Lujun,Luo Qisheng,Zhang Junyi,et al.GRP78 overexpression as an unfavorable outcome in glioma patients.[J].International journal of clinical and experimental pathology.2018,11(1):420-426.
APA:
Bao Lujun,Luo Qisheng,Zhang Junyi&Lao Zhiyun.(2018).GRP78 overexpression as an unfavorable outcome in glioma patients..International journal of clinical and experimental pathology,11,(1)
MLA:
Bao Lujun,et al."GRP78 overexpression as an unfavorable outcome in glioma patients.".International journal of clinical and experimental pathology 11..1(2018):420-426